REPLIGEN CORP (RGEN) Institutional Ownership and Insiders Activity
REPLIGEN CORP (RGEN) is widely held by institutional investors, with 490 firms reporting positions valued at approximately $8.93B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $734.72M in RGEN holdings in its latest filing.
Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
490
Total Reported Value
$8.93B
Largest Holder
Blackrock, Inc.
Largest Position
$734.72M
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
452
Funds Exiting Positions
3
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$734.72M
- Fmr Llc$453.89M
- United Capital Financial Advisors, Llc$380.76M
- Vanguard Capital Management Llc$328.98M
- Vanguard Portfolio Management Llc$315.56M
Related RGEN Institutional Insights:
- RGEN 13F Institutional Holders
- RGEN Superinvestors
- RGEN Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RGEN Insider Trading & SEC Form 4 Activity
- RGEN Articles
- Top Institutional Investor Stock Rankings